Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

证券代码：605567 证券简称：春雪食品 公告编号：2025-061 春雪食品集团股份有限公司关于获得政府补助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、获得补助的基本情况 2025年11月24日，春雪食品集团股份有限公司（以下简称"公司"）收到与 收益相关的政府补助资金379.00万元，占公司最近一个会计年度经审计归属于上 市公司股东净利润的46.42%。 二、补助的类型及其对上市公司的影响 公司根据《企业会计准则第16号--政府补助》的相关规定，确认上述事项并 划分补助类型。上述政府补助未经审计，具体会计处理以及对公司损益的影响最 终以审计机构年度审计确认后的结果为准，敬请广大投资者注意投资风险。 特此公告。 春雪食品集团股份有限公司董事会 2025 年 11 月 25 日 1 ...

Core Viewpoint - Spring Snow Food (605567) announced on November 24 that it received government subsidy funds related to revenue amounting to 3.79 million yuan, which accounts for 46.42% of the company's audited net profit attributable to shareholders for the most recent fiscal year [1] Summary by Category - **Government Subsidy** - The company received a government subsidy of 3.79 million yuan [1] - This subsidy represents 46.42% of the company's audited net profit attributable to shareholders for the last fiscal year [1]

Core Viewpoint - Spring Snow Food reported a decrease in the number of shareholders, indicating potential concerns regarding investor confidence and stock performance [2] Shareholder Information - As of November 20, the number of shareholders for Spring Snow Food was 13,782, a decrease of 1,093 from the previous period (November 10), representing a decline of 7.35% [2] - This marks the second consecutive period of decline in the number of shareholders [2] Stock Performance - The closing price of Spring Snow Food on the reporting date was 10.97 yuan, down 4.02%, with a cumulative decline of 3.77% since the concentration of shares began [2] - The stock experienced 4 days of increases and 5 days of decreases during this period [2] Financial Performance - For the first three quarters, Spring Snow Food achieved a revenue of 1.912 billion yuan, reflecting a year-on-year growth of 5.95% [2] - The net profit for the same period was 33.87 million yuan, showing a significant year-on-year increase of 1,320.44% [2] - The basic earnings per share were reported at 0.1700 yuan, with a weighted average return on equity of 3.11% [2]

Market Overview - The food processing sector increased by 0.89% on November 13, with Hai Xin Food leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Individual Stock Performance - Hai Xin Food (002702) closed at 5.91, up 10.06% with a trading volume of 638,700 shares and a transaction value of 356 million [1] - Hui Fa Food (603536) closed at 13.58, up 3.51% with a trading volume of 337,000 shares [1] - Anjij Food (603345) closed at 83.50, up 2.81% with a trading volume of 118,900 shares [1] - Other notable stocks include Ba Bi Food (605338) at 31.86 (+1.89%), Xi Wang Food (000639) at 3.53 (+1.73%), and De Li Si (002330) at 5.40 (+1.50%) [1] Capital Flow Analysis - The food processing sector experienced a net outflow of 12.08 million from institutional investors and 34.16 million from speculative funds, while retail investors saw a net inflow of 46.24 million [2] - Hai Xin Food had a net inflow of 52.30 million from institutional investors, but a net outflow of 23.73 million from speculative funds [3] - Anjij Food saw a net inflow of 23.88 million from institutional investors, with a net outflow of 16.29 million from speculative funds [3]

Core Viewpoint - The food processing sector experienced a slight increase of 0.37% on November 11, with Gais Food leading the gains, while the overall market indices saw declines [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4002.76, down 0.39%, and the Shenzhen Component Index closed at 13289.0, down 1.03% [1]. - Gais Food's stock price rose by 4.89% to 15.86, with a trading volume of 270,200 shares and a transaction value of 419 million yuan [1]. Group 2: Individual Stock Performance - Other notable gainers included: - Kangbiter, up 4.65% to 18.92, with a trading volume of 53,400 shares and a transaction value of 99.55 million yuan [1]. - Babi Food, up 4.43% to 32.08, with a trading volume of 167,500 shares and a transaction value of 530 million yuan [1]. - Haixin Food, up 3.12% to 5.29, with a trading volume of 397,300 shares and a transaction value of 208 million yuan [1]. Group 3: Capital Flow - The food processing sector saw a net outflow of 159 million yuan from institutional investors, while retail investors contributed a net inflow of 100 million yuan [2]. - Gais Food had a net inflow of 25.86 million yuan from retail investors, indicating strong interest from individual investors [3].

Core Viewpoint - The white feather broiler industry is experiencing a downturn in 2025, with prices dropping to "10 yuan for 3 jin" and "10 yuan for 4 jin," prompting companies like Chunxue Food to seek high-end market opportunities and expand internationally [1][2] Company Performance - Chunxue Food reported a net profit increase of 1320.44% year-on-year for the first three quarters of 2025, with third-quarter profit growth significantly outpacing revenue growth [1] - The increase in profit is attributed to a rise in export product revenue and a decrease in the costs of purchased chick seedlings and feed materials, leading to improved profit margins [1] Strategic Initiatives - The company is focusing on enhancing fresh product sales management and increasing the value of its chicken products by entering high-end retail channels such as Sam's Club and certain supermarkets [1] - Chunxue Food aims to adjust its product structure to improve the quality of chicken products and increase the sales proportion of high-value-added products [1] Industry Trends - The industry is undergoing a transformation from scale expansion to value reconstruction, shifting from "quantity increase" to "quality change," entering a period of deep reshuffling and integration focused on "quality and branding" [2] - The company plans to advance towards the high-end of the industry chain, facing more "value competition" rather than "price competition" [2] Production Capacity - Chunxue Food is installing two new processing lines for prepared products, which are expected to be operational by the end of November, increasing the annual production capacity for prepared products to 136,000 tons [2] International Market Expansion - The company is accelerating its "brand going global" strategy, focusing on expanding into European and Southeast Asian markets to promote brand internationalization [2] - Chunxue Food is currently engaged in sales activities in Southeast Asia but has no plans to establish production and sales centers or factories there [3] Export Performance - According to customs data, China's chicken meat exports reached 613,800 tons from January to October 2025, marking a year-on-year increase of 37.7%, with October alone seeing exports of 70,800 tons, a record high [3]

Core Viewpoint - The company, Chunxue Food (605567.SH), clarified on its investor interaction platform that it does not produce pet food [1] Company Summary - Chunxue Food has confirmed that its product line does not include pet food, indicating a focused business strategy [1]

Group 1 - The artificial meat concept stocks experienced a short-term surge, with Guoen Co., Ltd. hitting the daily limit up [1] - Fuxiang Pharmaceutical saw an increase of over 15% [1] - Other companies such as Huabao Co., Haoxiangni, Shuanghui Development, Chengzhi Co., and Chunxue Food also experienced gains [1]

Group 1 - The company has completed the sale of 750,000 shares from its employee stock ownership plan (ESOP) after the first lock-up period, while still holding another 750,000 shares that remain locked [1][3] - The ESOP was approved during the board and supervisory meetings held on September 27, 2023, and further details were disclosed on October 13, 2023 [1] - The first meeting of the ESOP holders took place on November 17, 2023, establishing the management committee and electing its members [2] Group 2 - On December 26, 2023, the company received a transfer confirmation for 1.5 million shares, which were transferred to the ESOP account at a price of 6.45 yuan per share, representing 0.75% of the total share capital [2] - The management committee will decide on the sale of the remaining shares based on market conditions after the first lock-up period [3] - The total shares sold from the ESOP accounted for 0.375% of the company's total share capital [3]